THOMAS DANIEL AICHER,STEVEN ARMEN BOYD,MARK JOSEPH CHICARELLI,KEVIN RONALD CONDROSKI,JAY BRADFORD FELL,JOHN P. FISCHER,INDRANI W. GUNAWARDANA,RONALD JAY HINKLIN,AJAY SINGH,TIMOTHY M. TURNER,ELI M. WAL
申请号：
BRPI0816881
公开号：
BRPI0816881A2
申请日:
2008.09.15
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
Provided are compounds of Formula I wherein R 2 , R 3 , R 13 , L and D 2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.
